The influence of baseline exercise tolerance on long-term efficacy outcomes following endoscopic thermal vapor ablation (InterVaporÔ) in patients with heterogeneous emphysema

A. Valipour, F.J.F. Herth, A. Ernst, P. Hopkins, J.J. Egan, F. Stanzel, M. Wagner, C. Witt, K. Baker, M.H. Gotfried, S. Kesten, G. Snell (Vienna, Austria; Heidelberg, , Berlin, Germany; Boston, Iowa City, Phoenix, Tustin, United States Of America; Chermside, Melbourne, Australia; Dublin, Ireland)

Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence
Session: Endoscopic lung volume reduction: the growing evidence
Session type: Oral Presentation
Number: 4726
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Valipour, F.J.F. Herth, A. Ernst, P. Hopkins, J.J. Egan, F. Stanzel, M. Wagner, C. Witt, K. Baker, M.H. Gotfried, S. Kesten, G. Snell (Vienna, Austria; Heidelberg, , Berlin, Germany; Boston, Iowa City, Phoenix, Tustin, United States Of America; Chermside, Melbourne, Australia; Dublin, Ireland). The influence of baseline exercise tolerance on long-term efficacy outcomes following endoscopic thermal vapor ablation (InterVaporÔ) in patients with heterogeneous emphysema. Eur Respir J 2012; 40: Suppl. 56, 4726

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Associations among one-year efficacy outcomes following endoscopic thermal vapor ablation (InterVaporÔ) for heterogeneous emphysema
Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence
Year: 2012

Associations of efficacy outcomes following bronchoscopic thermal vapor ablation (BTVA) for the treatment of heterogeneous emphysema
Source: Annual Congress 2011 - Treatment beyond inhalers: endoscopic lung volume reduction
Year: 2011


The influence of emphysema heterogeneity on the magnitude of benefit following endoscopic thermal vapor ablation (InterVaporÔ) in patients with heterogeneous emphysema
Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence
Year: 2012


Germany pilot safety and feasibility study of bronchoscopic thermal vapor ablation (BTVA) for lung volume reduction in patients with heterogeneous emphysema with upper lobe predominance
Source: Annual Congress 2009 - Treatment beyond inhalers
Year: 2009


Impact of radiological changes on treatment outcome following endoscopic lung volume reduction with coils (LVRC) in patients with advanced emphysema
Source: International Congress 2018 – Endoscopic lung volume reduction
Year: 2018



Sustained efficacy from 3 to 6 months following bronchoscopic thermal vapor ablation (BTVA) in the treatment of heterogeneous emphysema
Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope?
Year: 2011


Combined exercise programs in patients with stable COPD: influence of psychological profile and monitoring
Source: Eur Respir J 2002; 20: Suppl. 38, 18s
Year: 2002

The effect of endoscopic lung volume reduction on functional outcomes in patients with severe emphysema.
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019

A safety and feasibility study of the chartis system in subjects with heterogeneous emphysema prior to endobronchial lung volume reduction (ELVR)
Source: Annual Congress 2009 - Treatment beyond inhalers
Year: 2009


Endoscopic lung volume reduction with nitinol coils in very severe emphysema: Mid-term effectiveness vs. disease related continuous loss of lung function
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015

Bronchodilation or pulmonary rehabilitation:which test of exercise performance yields the greatest response for patients with stable COPD? An RCT.
Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases
Year: 2018



Endoscopic lung volume reduction (ELVR) treatment for patients with severe heterogeneous emphysema and bilateral incomplete fissures. Effectiveness and complications of coils´ implantation at 90 days follow up
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015


Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema
Source: Eur Respir J 2012; 39: 1326-1333
Year: 2012



Nasal high flow therapy: The effect on exercise performance in patients with COPD
Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD?
Year: 2018



The effect of pulmonary rehabilitation on exercise tolerance and quality of life in patients with COPD. Preliminary data
Source: Eur Respir J 2001; 18: Suppl. 33, 223s
Year: 2001

Long-term (1-year) effects of two methods of exercise training (ET) in COPD patients
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010

Long-term effects of high-intensity exercise training in patients with COPD: a controlled study
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019

Efficacy and effectiveness in long-term treatment with different ”new[dcdquote] drug's associations in cold patients
Source: Eur Respir J 2003; 22: Suppl. 45, 52s
Year: 2003

Impact of exercise modality on exercise tolerance and functional capacity in patients with COPD
Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention
Year: 2010

The effect of pulmonary rehabilitation before bronchoscopic volume reduction on post-procedure clinical status and follow-up compliance
Source: Virtual Congress 2020 – Novel insights into exercise training
Year: 2020